🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 10 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/10/2002 33,00 33,18 31,86 32,82 +0,00% 4,00% 7.717
03/10/2002 31,62 33,00 31,50 32,82 +1,86% 4,74% 13.650
02/10/2002 30,96 32,40 30,96 32,22 +2,29% 4,65% 18.133
01/10/2002 32,16 32,40 29,88 31,50 -0,76% 7,84% 34.700
30/09/2002 31,80 32,10 30,00 31,74 -0,94% 6,60% 20.883
27/09/2002 31,02 32,10 30,66 32,04 +3,09% 4,64% 23.567
26/09/2002 30,30 31,08 30,12 31,08 +2,78% 3,17% 19.850
25/09/2002 27,06 30,24 26,94 30,24 +12,50% 12,20% 27.333
24/09/2002 25,44 27,60 25,38 26,88 +0,67% 8,73% 18.733
23/09/2002 26,46 27,00 25,50 26,70 -2,20% 5,67% 27.100
20/09/2002 29,34 29,88 27,00 27,30 -7,71% 9,82% 27.900
19/09/2002 29,88 29,94 29,22 29,58 -1,40% 2,41% 12.450
18/09/2002 29,52 30,90 28,80 30,00 +0,20% 7,11% 20.150
17/09/2002 30,24 30,54 29,04 29,94 -1,19% 4,96% 14.100
16/09/2002 31,14 31,20 30,12 30,30 -2,51% 3,47% 16.300
13/09/2002 28,86 31,14 28,62 31,08 +6,37% 8,73% 19.183
12/09/2002 30,72 31,50 28,80 29,22 -5,44% 8,79% 36.600
11/09/2002 30,12 30,90 29,70 30,90 +3,83% 3,98% 20.600
10/09/2002 30,60 30,72 29,46 29,76 -3,69% 4,12% 16.817
09/09/2002 29,70 31,20 29,70 30,90 +3,21% 5,05% 34.100
06/09/2002 28,56 30,00 28,32 29,94 +5,05% 5,88% 32.533
05/09/2002 26,04 28,50 25,50 28,50 +9,70% 11,52% 40.650
04/09/2002 23,76 25,98 23,76 25,98 +8,25% 9,34% 26.800
03/09/2002 23,52 24,60 23,10 24,00 +0,76% 6,38% 18.583
30/08/2002 23,40 23,82 22,68 23,82 +1,79% 4,87% 16.633
29/08/2002 23,46 23,70 22,92 23,40 +0,00% 3,32% 16.467
28/08/2002 22,68 23,40 22,02 23,40 +4,56% 6,08% 18.633
27/08/2002 22,38 23,40 21,60 22,38 +0,81% 8,04% 11.933
26/08/2002 21,60 22,20 20,22 22,20 -0,54% 9,17% 12.850
23/08/2002 21,48 22,32 21,00 22,32 +5,08% 6,15% 5.917